Cargando…

Current Options for Second-Line Systemic Therapy in Metastatic Renal Cell Carcinoma

Standard systemic therapy of advanced renal cell carcinoma (RCC) involves targeting angiogenesis, mainly through tyrosine kinase inhibitors (TKI) against the vascular endothelial growth factor receptor (VEGFR) pathway and targeting the immune checkpoints, namely, programmed death-1 (PD-1) or its lig...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mitsogiannis, Iraklis C., Mitsogianni, Maria, Papathanassiou, Maria, Anagnostou, Maria, Tamposis, Ioannis, Mitrakas, Lampros, Samara, Maria, Tzortzis, Vassilios, Vlachostergios, Panagiotis J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Codon Publications 2022
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9551369/ https://www.ncbi.nlm.nih.gov/pubmed/36310639 http://dx.doi.org/10.15586/jkcvhl.v9i3.243

Ejemplares similares

Hypoxia-Inducible Factor-2-Altered Urothelial Carcinoma: Clinical and Genomic Features
por: Vlachostergios, Panagiotis J., et al.
Publicado: (2022)

DNA Repair Gene Polymorphisms and Susceptibility to Urothelial Carcinoma in a Southeastern European Population
por: Samara, Maria, et al.
Publicado: (2021)

Immune-based treatment re-challenge in renal cell carcinoma: A systematic review and meta-analysis
por: Papathanassiou, Maria, et al.
Publicado: (2022)

Health-Related Quality of Life Assessment in Daily Urologic Practice: A Survey of Greek Urologists
por: Mitsogiannis, Iraklis C, et al.
Publicado: (2022)

Characterization of a miRNA Signature with Enhanced Diagnostic and Prognostic Power for Patients with Bladder Carcinoma
por: Samara, Maria, et al.
Publicado: (2023)

Renin-Angiotensin System Single Nucleotide Polymorphisms Are Associated with Bladder Cancer Risk
por: Samara, Maria, et al.
Publicado: (2021)

Upper Tract Urothelial Carcinoma: A Rare Malignancy with Distinct Immuno-Genomic Features in the Era of Precision-Based Therapies
por: Evmorfopoulos, Konstantinos, et al.
Publicado: (2023)

Radiofrequency-assisted, laparoscopic, clampless partial nephrectomy in patients with low-complexity small renal tumors: A retrospective cohort study
por: Zachos, Ioannis, et al.
Publicado: (2023)

Clear-cell renal cell carcinoma single urinary bladder metastasis: a case report and review of the literature
por: Zachos, Ioannis, et al.
Publicado: (2022)

Lymphoepithelioma-Like Carcinoma of the Urinary Bladder: A Case Report and Review of the Literature
por: Mitsogiannis, Iraklis, et al.
Publicado: (2022)

Mixed epithelial and stromal tumor—adult cystic nephroma of the kidney: a case report with immunohistochemical analysis
por: Karasavvidou, Foteini, et al.
Publicado: (2022)

Liposarcoma of the Spermatic Cord Mimicking an Inguinal Hernia: A Case Report and Literature Review
por: Pikramenos, Konstantinos, et al.
Publicado: (2022)

Poorly differentiated muscle-invasive giant cell tumor of the bladder leads to unfavorable clinical outcome
por: Karasavvidou, Foteini, et al.
Publicado: (2022)

Biomarkers in Prostate-Specific Membrane Antigen Theranostics
por: Vlachostergios, Panagiotis J., et al.
Publicado: (2021)

Expression of Fibroblast Activation Protein Is Enriched in Neuroendocrine Prostate Cancer and Predicts Worse Survival
por: Vlachostergios, Panagiotis J., et al.
Publicado: (2022)

Early mRNA Expression of Neuroendocrine Differentiation Signals Predicts Recurrence After Radical Prostatectomy: A Transcriptomic Analysis
por: Vlachostergios, Panagiotis J., et al.
Publicado: (2021)

Cefixime versus prulifloxacin as a prophylactic treatment for prostate biopsy: a randomized study
por: Samarinas, Michael, et al.
Publicado: (2020)

PCaGuard: A Software Platform to Support Optimal Management of Prostate Cancer
por: Tamposis, Ioannis, et al.
Publicado: (2022)

Post Radical Prostatectomy Erectile Dysfunction. A Single Centre Experience
por: Pikramenos, Konstantinos, et al.
Publicado: (2023)

Complete Vascular Replacement of the Infrarenal Inferior Vena Cava and Abdominal Aorta during Post-Chemotherapy Retroperitoneal Lymph Node Dissection for a Non-Seminomatous Germ Cell Tumor
por: Evmorfopoulos, Konstantinos, et al.
Publicado: (2023)

A Rare Case of an Intermittent Urinary Catheter Discovered Inside a Bladder
por: Pikramenos, Konstantinos, et al.
Publicado: (2022)

Optimal Delivery of Follow-Up Care for the Prevention of Stone Recurrence in Urolithiasis Patients: Improving Outcomes
por: Tzelves, Lazaros, et al.
Publicado: (2022)

Relugolix: A new kid on the block among gonadotrophin-releasing hormone antagonists
por: Fragkoulis, Charalampos, et al.
Publicado: (2021)

Second-line treatment options in hepatocellular carcinoma
por: Marino, Donatella, et al.
Publicado: (2019)

Resistance to Pembrolizumab and Axitinib in Renal Cell Carcinoma: Clinical and Genomic Evaluation
por: Vlachostergios, Panagiotis J.
Publicado: (2020)

Cost-Effectiveness of the First Line Treatment Options For Metastatic Renal Cell Carcinoma in India
por: Gupta, Dharna, et al.
Publicado: (2023)

Optimal first-line and second-line treatments for metastatic renal cell carcinoma: current evidence
por: Sun, Maxine, et al.
Publicado: (2014)

Inflammatory Myofibroblastic Bladder Tumor in a Patient with Von Recklinghausen's Syndrome
por: Chatzidarellis, Eleftherios, et al.
Publicado: (2010)

Second-Line Treatment of Metastatic Renal Cell Carcinoma in the Era of Predictive Biomarkers
por: Parosanu, Andreea Ioana, et al.
Publicado: (2023)

Implication of First-Line Antiretroviral Therapy Choice on Second-Line Options
por: Meloni, Seema T, et al.
Publicado: (2017)

Basic Concepts in Metastatic Cardiac Disease
por: Vlachostergios, Panagiotis J., et al.
Publicado: (2012)

Metastatic clear cell renal carcinoma – an unusual response to Temsirolimus in second line therapy
por: Stanculeanu, DL, et al.
Publicado: (2016)

A case of penile strangulation after placement of metallic rings
por: Mitsogiannis, Iraklis C., et al.
Publicado: (2018)

Previous Bladder Cancer History in Patients with High-Risk, Non–muscle-invasive Bladder Cancer Correlates with Recurrence and Progression: Implications of Natural History
por: Mitrakas, Lampros P., et al.
Publicado: (2015)

Sharp Second-Order Pointwise Asymptotics for Lossless Compression with Side Information
por: Gavalakis, Lampros, et al.
Publicado: (2020)

Uretero-Ureterostomy Combined With Unilateral Nephrostomy as a Method of Urinary Diversion Following Radical Cystectomy
por: Papadimitriou, Christos, et al.
Publicado: (2022)

Current Management Options in Metastatic Renal Cell Cancer
por: Gangadaran, Sittu Govindasamy Dinakaran
Publicado: (2017)

New treatment options for metastatic renal cell carcinoma
por: Rodriguez-Vida, Alejo, et al.
Publicado: (2017)

Biomarkers defining probability of receiving second-line targeted therapy in metastatic renal cell carcinoma
por: Chrom, Pawel, et al.
Publicado: (2018)

Predictive Factors for Second-Line Therapy in Metastatic Renal Cell Carcinoma: A Retrospective Analysis
por: Eggers, Hendrik, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_pl5aqdhmbs3dlaoktvf9f1625k